|
| 36530033 | Reply. | | 2023 |
| 35866713 | Rheumatoid Arthritis Disease Activity and Hospitalized Infection in a Large US Registry. | Arthritis Care and Research | 2023 |
| 34654733 | Dr. Kremer et al reply. | Journal of Rheumatology | 2022 |
| 33323534 | The Clinical Disease Activity Index and the Routine Assessment of Patient Index Data 3 for Achievement of Treatment Strategies. | Journal of Rheumatology | 2021 |
| 32374918 | Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis. | Arthritis Care and Research | 2021 |
| 32358158 | Evaluation of Changes in Skin and Joint Outcomes and Associated Treatment Changes in Psoriatic Arthritis (PsA): Experience From the Corrona PsA/SpA Registry. | Journal of Rheumatology | 2021 |
| 33570260 | Postapproval Comparative Safety Study of Tofacitinib and Biological Disease-Modifying Antirheumatic Drugs: 5-Year Results from a United States-Based Rheumatoid Arthritis Registry. | ACR Open Rheumatology | 2021 |
| 33934070 | Predicting Response to Tocilizumab Monotherapy in Rheumatoid Arthritis: A Real-world Data Analysis Using Machine Learning. | J Rheumatol | 2021 |
| 33034006 | Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis. | Advances in Therapy | 2021 |
| 31371657 | Longterm, Real-world Safety of Adalimumab in Rheumatoid Arthritis: Analysis of a Prospective US-based Registry. | Journal of Rheumatology | 2020 |
| 32027420 | The National Psoriasis Foundation psoriasis treatment targets in real-world patients: prevalence and association with patient-reported outcomes in the Corrona Psoriasis Registry. | Journal of the European Academy of Dermatology and Venereology | 2020 |
| 32103630 | Physician Prescribing Patterns and Risk of Future Long-Term Opioid Use Among Patients With Rheumatoid Arthritis: A Prospective Observational Cohort Study. | Arthritis and Rheumatology | 2020 |
| 32759265 | Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data. | Annals of the Rheumatic Diseases | 2020 |
| 33161375 | Hydroxychloroquine and the risk of respiratory infections among RA patients. | RMD Open | 2020 |
| 31321485 | Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis in a real-world setting. | Rheumatology International | 2019 |
| 31647025 | Molecular profiling of rheumatoid arthritis patients reveals an association between innate and adaptive cell populations and response to anti-tumor necrosis factor. | Arthritis Res Ther | 2019 |
| 30474933 | Chronic Opioid Use in Rheumatoid Arthritis: Prevalence and Predictors. | Arthritis and Rheumatology | 2019 |
| 30647182 | Predictors of Achieving Remission among Patients with Psoriatic Arthritis Initiating a Tumor Necrosis Factor Inhibitor. | Journal of Rheumatology | 2019 |
| 31529278 | Comparative Disease Burden in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from Two Corrona Registries. | Rheumatology and Therapy | 2019 |
| 31168408 | Discontinuation and switching patterns of tumour necrosis factor inhibitors (TNFis) in TNFi-naive and TNFi-experienced patients with psoriatic arthritis: an observational study from the US-based Corrona registry. | RMD Open | 2019 |
| 31005939 | Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry. | BMJ Open | 2019 |
| 30673733 | Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis. | PLoS One | 2019 |
| 30663130 | Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross-sectional analysis from the US-based Corrona Psoriasis Registry. | Journal of the European Academy of Dermatology and Venereology | 2019 |
| 31245045 | Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry. | RMD Open | 2019 |
| 29409118 | Evaluation of a Methodologic Approach to Define an Inception Cohort of Rheumatoid Arthritis Patients Using Administrative Data. | Arthritis Care and Research | 2018 |
| 28947312 | Influence of obesity, age, and comorbidities on the multi-biomarker disease activity test in rheumatoid arthritis. | Seminars in Arthritis and Rheumatism | 2018 |
| 28544704 | Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-to-Target Approach to Care of US Patients With Rheumatoid Arthritis. | Arthritis Care and Research | 2018 |
| 28448195 | Design characteristics of the Corrona Japan rheumatoid arthritis registry. | Modern Rheumatology | 2018 |
| 28966209 | Rebound in Measures of Disease Activity and Symptoms in Corrona Registry Patients with Psoriatic Arthritis Who Discontinue Tumor Necrosis Factor Inhibitor Therapy after Achieving Low Disease Activity. | Journal of Rheumatology | 2018 |
| 29051036 | Characterization of disease burden, comorbidities, and treatment use in a large, US-based cohort: Results from the Corrona Psoriasis Registry. | Journal of the American Academy of Dermatology | 2018 |
| 30353387 | Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona Registry. | Rheumatology and Therapy | 2018 |
| 29961691 | Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis: Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. | Journal of Rheumatology | 2018 |
| 29869112 | Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis. | Clinical Rheumatology | 2018 |
| 30622736 | Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation. | RMD Open | 2018 |
| 29707232 | Baseline patient characteristics associated with response to biologic therapy in patients with psoriatic arthritis enrolled in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. | RMD Open | 2018 |
| 29696436 | Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study. | Clin Rheumatol | 2018 |
| 29329557 | One-year risk of serious infection in patients treated with certolizumab pegol as compared with other TNF inhibitors in a real-world setting: data from a national U.S. rheumatoid arthritis registry. | | 2018 |
| 29409123 | Characterization of Patients With Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis in the US-Based Corrona Registry. | Arthritis Care and Research | 2018 |
| 28292303 | Sex differences in gout characteristics: tailoring care for women and men. | BMC Musculoskeletal Disorders | 2017 |
| 28647488 | Autoreactivity to malondialdehyde-modifications in rheumatoid arthritis is linked to disease activity and synovial pathogenesis. | Journal of Autoimmunity | 2017 |
| 28340006 | Benefit of biologics initiation in moderate versus severe rheumatoid arthritis: evidence from a United States registry. | Rheumatology | 2017 |
| 28376239 | Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. | Arthritis Care and Research | 2017 |
| 28718043 | Impact of rituximab on patient-reported outcomes in patients with rheumatoid arthritis from the US Corrona Registry. | Clinical Rheumatology | 2017 |
| 28936808 | Impact of Tocilizumab Monotherapy on Clinical and Patient-Reported Quality-of-Life Outcomes in Patients with Rheumatoid Arthritis. | Rheumatology and Therapy | 2017 |
| 28620063 | Clinical and Patient-reported Outcomes in Patients with Psoriatic Arthritis (PsA) by Body Surface Area Affected by Psoriasis: Results from the Corrona PsA/Spondyloarthritis Registry. | Journal of Rheumatology | 2017 |
| 29081988 | Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme. | RMD Open | 2017 |
| 28271234 | Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry. | Clinical Rheumatology | 2017 |
| 27788309 | Brief Report: The Role of Rare Protein-Coding Variants in Anti-Tumor Necrosis Factor Treatment Response in Rheumatoid Arthritis. | Arthritis Rheumatol | 2017 |
| 28118534 | Persistence of Disease-Associated Anti-Citrullinated Protein Antibody-Expressing Memory B Cells in Rheumatoid Arthritis in Clinical Remission. | Arthritis and Rheumatology | 2017 |
| 28028867 | The clinical status and economic savings associated with remission among patients with rheumatoid arthritis: leveraging linked registry and claims data for synergistic insights. | Pharmacoepidemiology and Drug Safety | 2017 |